ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

AstraZeneca · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
prevention of infectious disease caused by sars-cov-2, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 858534
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.